USD 19.6
(-0.56%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 102.24 Million USD | 9.39% |
2022 | 93.46 Million USD | 52.52% |
2021 | 61.27 Million USD | 122.56% |
2020 | 27.53 Million USD | 115.61% |
2019 | 12.77 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 22.62 Million USD | -8.42% |
2024 Q1 | 24.7 Million USD | -0.47% |
2023 Q3 | 24.47 Million USD | -11.04% |
2023 FY | 102.24 Million USD | 9.39% |
2023 Q4 | 24.82 Million USD | 1.43% |
2023 Q2 | 27.51 Million USD | 8.17% |
2023 Q1 | 25.43 Million USD | 13.01% |
2022 Q2 | 24.24 Million USD | 10.1% |
2022 Q1 | 22.02 Million USD | 11.93% |
2022 FY | 93.46 Million USD | 52.52% |
2022 Q4 | 22.5 Million USD | -8.86% |
2022 Q3 | 24.69 Million USD | 1.86% |
2021 FY | 61.27 Million USD | 122.56% |
2021 Q4 | 19.67 Million USD | 12.67% |
2021 Q3 | 17.46 Million USD | 25.77% |
2021 Q1 | 10.26 Million USD | 35.29% |
2021 Q2 | 13.88 Million USD | 35.29% |
2020 FY | 27.53 Million USD | 115.61% |
2020 Q4 | 7.58 Million USD | -2.48% |
2020 Q3 | 7.77 Million USD | 14.92% |
2020 Q2 | 6.76 Million USD | 25.26% |
2020 Q1 | 5.4 Million USD | 0.0% |
2019 FY | 12.77 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Akoya Biosciences, Inc. | 104.27 Million USD | 1.944% |
AngioDynamics, Inc. | 252.41 Million USD | 59.494% |
AtriCure, Inc. | 327.05 Million USD | 68.738% |
Avinger, Inc. | 18.63 Million USD | -448.573% |
Azenta, Inc. | 336.26 Million USD | 69.595% |
BioLife Solutions, Inc. | 117.57 Million USD | 13.042% |
The Cooper Companies, Inc. | 1.82 Billion USD | 94.397% |
Daxor Corporation | 1.28 Million USD | -7884.522% |
Ekso Bionics Holdings, Inc. | 24.19 Million USD | -322.649% |
Femasys Inc. | 15.2 Million USD | -572.637% |
GlucoTrack, Inc. | 7.1 Million USD | -1339.231% |
Harvard Bioscience, Inc. | 58.58 Million USD | -74.533% |
Hologic, Inc. | 1.34 Billion USD | 92.399% |
ICU Medical, Inc. | 717.04 Million USD | 85.741% |
Intuitive Surgical, Inc. | 2.96 Billion USD | 96.549% |
KORU Medical Systems, Inc. | 26.1 Million USD | -291.618% |
LeMaitre Vascular, Inc. | 90.33 Million USD | -13.18% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | 85781.603% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | 85781.603% |
Masimo Corporation | 867 Million USD | 88.207% |
Microbot Medical Inc. | 9.85 Million USD | -937.473% |
Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | -455.063% |
Merit Medical Systems, Inc. | 459.92 Million USD | 77.77% |
Nephros, Inc. | 9.78 Million USD | -945.002% |
NovoCure Limited | 613.92 Million USD | 83.346% |
NEXGEL, Inc. | 4.09 Million USD | -2396.167% |
NEXGEL, Inc. | 4.09 Million USD | -2396.167% |
OraSure Technologies, Inc. | 125.34 Million USD | 18.429% |
Pro-Dex, Inc. | 7.37 Million USD | -1285.782% |
Pulse Biosciences, Inc. | 43.57 Million USD | -134.642% |
Predictive Oncology Inc. | 15.22 Million USD | -571.347% |
Precision Optics Corporation, Inc. | 8.52 Million USD | -1099.738% |
QuidelOrtho Corporation | 1.35 Billion USD | 92.456% |
Repligen Corporation | 261.12 Million USD | 60.845% |
Sanara MedTech Inc. | 61.12 Million USD | -67.263% |
STAAR Surgical Company | 224.55 Million USD | 54.468% |
Sharps Technology, Inc. | 10.12 Million USD | -909.643% |
Utah Medical Products, Inc. | 13.26 Million USD | -671.005% |
DENTSPLY SIRONA Inc. | 1.79 Billion USD | 94.301% |
Jin Medical International Ltd. | 3.91 Million USD | -2509.856% |